Delayed oseltamivir treatment is associated with longer viral shedding of pandemic (H1N1) 2009 virus

Epidemiology and Infection

Volumn 140, Issue 5, 2012, Pages 814-817

  Leung, Y H ^a   Lim, W L ^a   Wong, M H ^a   Chuang, S K ^a  

^a DEPARTMENT OF HEALTH   (Hong Kong)

Author keywords

Influenza; swine origin influenza A(H1N1) virus; virus shedding

Indexed keywords

OSELTAMIVIR;

2009 H1N1 INFLUENZA; ADULT; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; GENOME ANALYSIS; HUMAN; INFECTION RISK; INFLUENZA VIRUS A H1N1; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; NONHUMAN; OUTCOME ASSESSMENT; PRESCHOOL CHILD; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RISK ASSESSMENT; THERAPY DELAY; VIRUS CULTURE; VIRUS GENOME; VIRUS SHEDDING;

ADOLESCENT; ADULT; ANTIVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; MIDDLE AGED; OSELTAMIVIR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; TIME FACTORS; VIRUS SHEDDING; YOUNG ADULT;

EID: 84859369759     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268811001415     Document Type: Review

References (12)

1. Centers for Disease Control and Prevention. Swine influenza A (H1N1) infection in two children -southern California, March-April 2009. Morbidity and Mortality Weekly Report 2009; 58: 400-402.
2. Centers for Disease Control and Prevention. Outbreak of swine-origin influenza A (H1N1) virus infection -Mexico, March-April 2009. Morbidity and Mortality Weekly Report 2009; 58: 463-466.
3. World Health Organization. Press statement by WHO Director-General. 11 June 2009 (http://www.who.int/mediacentre/news/statements/2009/h1n1-pandemic- phase6-20090611/en/index.html). Accessed 1 February 2011.
4. Couch RB, Kasel JA. Influenza. In: Lennette EH, Lennette DA, Lennette ET, eds. Diagnostic Procedures for Viral, Rckettsial and Chlamydial infections, 7th edn. Washington: American Public Health Association, 1995, pp. 431-446.
5. Centre for Health Protection. CHP molecular diagnostic protocols for the detection of human swine influenza virus type A (subtype H1) revision 2 (26 December 2009). (http://www.chp.gov.hk/files/pdf/chp-protocols-for-the- detection-of-human-swine-influenza.pdf). Accessed 1 February 2011.
6. Ling LM, et al. Effects of early oseltamivir therapy on viral shedding in 2009 pandemic influenza A (H1N1) virus infection. Clinical Infectious Diseases 2010; 50: 963-969.
7. Witkop CT, et al. Novel Influenza A (H1N1) outbreak at the U.S. Air Force Academy: epidemiology and viral shedding duration. American Journal of Preventive Medicine 2010; 38: 121-126.
8. Aoki FY, et al. Early administration of oral oseltamivir increases the benefits of influenza treatment. Journal of Antimicrobial Chemotherapy 2003; 51: 123-129. (Pubitemid 36163836)
9. Kawai N, et al. Factors influencing the effectiveness of oseltamivir and amantadine for the treatment of influenza: A multicenter study from Japan of the 2002-2003 influenza season. Clinical Infectious Diseases 2005; 40: 1309-1316. (Pubitemid 40570241)
10. Cao B, et al. Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China. New England Journal of Medicine 2009; 361: 2507-2517.
11. Yu H, et al. Effectiveness of oseltamivir on disease progression and viral RNA shedding in patients with mild pandemic 2009 influenza A H1N1: opportunistic retrospective study of medical charts in China. British Medical Journal 2010; 341: c4779.
12. Li CC, et al. Correlation of pandemic (H1N1) 2009 viral load with disease severity and prolonged viral shedding in children. Emerging Infectious Diseases 2010; 16: 1265-1272.